文献速递肝病消化道肿瘤与早癌

多代母体肥胖通过miR-27a-3p增加子代肝细胞癌发病率

Multigenerational maternal obesity increases the incidence of HCC in offspring via miR-27a-3p.
PubMed 文献 · J Hepatol · 2020-06-25

本研究利用二乙基亚硝胺(DEN)在高脂饮食诱导的多代肥胖模型中诱导肝细胞癌(HCC),通过RNA测序发现miR-27a-3p及其靶基因Acsl1和Aldh2随代数逐渐改变。母体肥胖导致子代对DEN诱导HCC的易感性增加且逐代累积,机制涉及miR-27a-3p-Acsl1/Aldh2轴;在人类HCC的TCGA分析中,miR-27a-3p上调与Acsl1/Aldh2下调与生存负相关。

要点

  • 高脂饮食下母体肥胖使子代对DEN诱导HCC的易感性增加,且逐代累积。
  • miR-27a-3p直接靶向Acsl1和Aldh2,高脂条件下二者下调协同促进细胞增殖或肿瘤生长。
  • 孕期注射miR-27a-3p agomir可上调子代肝脏miR-27a-3p、下调Acsl1/Aldh2并加剧DEN处理子代的HCC发展。

核心结论

  • 母体肥胖通过miR-27a-3p-Acsl1/Aldh2轴调控子代多代累积的HCC易感性。

研究设计与样本

  • 研究采用DEN在高脂饮食诱导的多代肥胖模型中诱导HCC,并进行RNA测序以识别跨代改变的基因和microRNA。
  • 在细胞系和荷HCC裸鼠中评估miR-27a-3p-Acsl1/Aldh2轴的作用,并在孕鼠及其子代中研究其跨代影响。

主要发现

  • 高脂饮食应激下,母体肥胖导致子代对DEN诱导HCC的易感性,且该易感性逐代累积。
  • Acsl1和Aldh2作为miR-27a-3p的直接靶点,随代数逐渐改变;高脂条件下二者下调协同增加体外细胞增殖或体内肿瘤生长。
  • 瘤内注射miR-27a-3p agomir通过下调Acsl1和Aldh2加剧肿瘤生长,而注射antagomir则产生相反效果。
  • 高脂饮食母系血清miR-27a-3p水平随代数逐渐升高。
  • 孕期注射miR-27a-3p agomir不仅上调子代(胎儿、幼年和成年阶段)肝脏miR-27a-3p并下调Acsl1/Aldh2,还加剧DEN处理子代的HCC发展。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Obesity is an independent risk factor for malignancies, including hepatocellular carcinoma (HCC). However, it remains unknown whether maternal obesity affects the incidence of HCC in offspring. Thus, we aimed to investigate this association and its underlying mechanisms. METHODS: Diethylnitrosamine (DEN) was used to induce HCC in a high-fat diet (HFD)-induced multigenerational obesity model. RNA-sequencing was performed to identify the genes and microRNAs (miRNAs) that were altered over generations. The role of the miR-27a-3p-Acsl1/Aldh2 axis in HCC was evaluated in cell lines and HCC-bearing nude mice, and its intergenerational impact was studied in pregnant mice and their offspring. RESULTS: Under HFD stress, maternal obesity caused susceptibility of offspring to DEN-induced HCC, and such susceptibility was cumulative over generations. We identified that Acsl1 and Aldh2, direct targets of miR-27a-3p, were gradually changed over generations. Under hyperlipidemic conditions, downregulation of Acsl1 and Aldh2 increased cell proliferation (in vitro) or tumor growth (in vivo) in synergy. Intratumor injection of an miR-27a-3p agomir exacerbated tumor growth by downregulating Acsl1 and Aldh2; while intratumor injection of an miR-27a-3p antagomir had the opposite effect. Moreover, serum miR-27a-3p levels gradually increased in the HFD-fed maternal lineage over generations. Injecting pregnant mice with an miR-27a-3p agomir not only upregulated hepatic miR-27a-3p and downregulated Acsl1/Aldh2 in offspring (fetus, young and adult stages), but also exacerbated HCC development in DEN-treated offspring. In human HCC, upregulated miR-27a-3p and downregulated Acsl1/Aldh2 were negatively correlated with survival on TCGA analysis; while, hepatic miR-27a-3p was negatively correlated with Acsl1/Aldh2 expression in tumor/non-tumor tissues from fatty/non-fatty livers. CONCLUSIONS: Maternal obesity plays a role in regulating cumulative susceptibility to HCC development in offspring over multiple generations through the miR-27a-3p-Acsl1/Aldh2 axis. LAY SUMMARY: It is not currently known how maternal obesity affects the incidence of liver cancer in offspring. In this study, we identified a microRNA (miR-27a-3p) that was upregulated in obese mothers and could be passed on to their offspring. This microRNA enhanced the risk of liver cancer in offspring by regulating 2 genes (Acsl1 and Aldh2). This mechanism could be a future therapeutic target.

来源:J Hepatol,查看原文。版权归原作者所有。

引用

  1. Sun Y, Wang Q, Zhang Y, et al. Multigenerational maternal obesity increases the incidence of HCC in offspring via miR-27a-3p. J Hepatol. 2020. PMID: 32593682. doi:10.1016/j.jhep.2020.03.050

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。